Shareholders Equity: The sum of preferred and common equity items.
Autolus Therapeutics PLC Sponsored ADR (AUTL) had Shareholders Equity of $178.13M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$24.29M |
|
$-90.33M |
|
$25.33M |
|
$-1.04M |
|
$96.75M |
|
$-72.47M |
|
$-19.05M |
|
$-91.51M |
|
$-91.51M |
|
$-90.33M |
|
$-90.33M |
|
$-90.33M |
|
$-90.33M |
|
$-72.47M |
|
$-69.83M |
|
266.14M |
|
266.14M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$435.92M |
|
$63.56M |
|
$153.15M |
|
$589.07M |
|
$73.44M |
|
-- |
|
$337.50M |
|
$410.94M |
|
$178.13M |
|
$158.32M |
|
|
Shareholders Equity |
$178.13M |
266.14M |
|
| Cash Flow Statement Financials | |
$-283.57M |
|
$158.46M |
|
$-4.34M |
|
$228.81M |
|
$105.64M |
|
$-123.17M |
|
$14.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.29% |
|
-298.35% |
|
-298.35% |
|
-- |
|
-376.77% |
|
-371.90% |
|
$-302.61M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.76 |
|
1.01 |
|
89.02 |
|
-50.71% |
|
-57.06% |
|
-15.33% |
|
-50.71% |
|
$0.67 |
|
$-1.14 |
|
$-1.07 |
|